Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Syneos Health
Panel discussion illustrated how decentralized approaches can expand the possibilities of studies in rare diseases, such as cancers with rare genomic alterations.
Efforts to improve trial diversity predate COVID-19, but the pandemic’s disproportionate effects on minority communities have brought the issue to the forefront.
Newly public Aligos will team with Merck & Co. on oligonucleotide therapies for NASH. Maze Therapeutics launches ophthalmology and CV-focused spinouts with Alloy and BridgeBio.
- Contract Research Organization-CRO
- Medical Devices
- Other Names / Subsidiaries